Details of the Drug

General Information of Drug (ID: DMDU54Y)

Drug Name
IK-175
Indication
Disease Entry ICD 11 Status REF
Urothelial carcinoma 2C92.0 Phase 1 [1]
Drug Type
Small molecular drug
Cross-matching ID
PubChem CID
140944699
TTD ID
D5D6ZM

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Aryl hydrocarbon receptor (AHR) TT037IE AHR_HUMAN Antagonist [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04200963) A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Ikena Oncology.